Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men
- 1 March 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 16 (3) , 368-374
- https://doi.org/10.1161/01.atv.16.3.368
Abstract
Abstract The associations between abdominal visceral fat and the plasma hemostatic system were examined in 38-year-old healthy men (n=52) with a wide range of fatness and fat distribution. Plasma hemostatic factors and metabolic parameters, including glucose tolerance, were measured, and body fatness and adipose tissue distribution were assessed by using computed tomography. The men with more visceral fat (ie, higher than the median value [n=26]) had a less favorable metabolic profile than the men with less visceral fat (n=26). They also had significantly ( P <.05) higher plasma fibrinogen, factor VIII clotting activity, tissue-type plasminogen activator antigen, and plasminogen activator inhibitor–1 (PAI-1) activity (19.2±2.4 versus 8.5±1.6 AU/mL, P <.001) and lower basal tissue-type plasminogen activator activity. After adjustment for plasma insulin, the men with larger abdominal visceral fat area still had significantly higher plasma PAI-1 activity, but no difference was found in any of the other hemostatic factors. In multiple linear regression analysis, abdominal visceral fat area was a positive predictor of plasma PAI-1 activity, but it failed to show any significant association with other hemostatic factors after controlling for plasma insulin. These results suggest the presence of relationships between abdominal visceral fat and several plasma hemostatic factors that are largely mediated by concomitant alterations in plasma insulin concentration. In addition, our results suggest that abdominal accumulation of visceral fat is an independent predictor of plasma PAI-1 activity.Keywords
This publication has 23 references indexed in Scilit:
- Relationships of thrombosis and fibrinolysis to atherosclerosisCurrent Opinion in Lipidology, 1994
- Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden Monica studyJournal of Clinical Epidemiology, 1994
- Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy menAtherosclerosis, 1994
- Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy menEuropean Journal of Clinical Investigation, 1994
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- The status of PAI-1 as a risk factor for arterial and thrombotic disease: A reviewAtherosclerosis, 1992
- Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factorsAtherosclerosis, 1991
- Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: A cross-sectional study in Norsjö, SwedenJournal of Clinical Epidemiology, 1988